Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022

Iris Finci, Madelyn Yiseth Rojas Castro, Nabil Seyidov, Samir Mehdiyev, C. Jason McKnight, Barbara Mühlemann, Christian Drosten, Lindsey Duca, Richard Pebody, Esther Kissling, Mark A. Katz, Gahraman Hagverdiyev
doi: https://doi.org/10.1101/2023.10.20.23297300

Data Availability

The data are not publicly available due to privacy or ethical restrictions. The authors do not have consent from study participants to share the data.

Back to top
Posted October 25, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Relative vaccine effectiveness of a CoronaVac booster dose in preventing symptomatic SARS-CoV-2 infection among healthcare workers during an Omicron period in Azerbaijan, January–August 2022
Iris Finci, Madelyn Yiseth Rojas Castro, Nabil Seyidov, Samir Mehdiyev, C. Jason McKnight, Barbara Mühlemann, Christian Drosten, Lindsey Duca, Richard Pebody, Esther Kissling, Mark A. Katz, Gahraman Hagverdiyev
medRxiv 2023.10.20.23297300; doi: https://doi.org/10.1101/2023.10.20.23297300
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area